working capital because the debt collections from the overdue debtors are more effective, and the management of the trade creditors is better; 2. A decrease of the investment in the trading securities in a
, showing a decrease of Baht 55.30 million or representing 24.14 % decrease since there have been only 5 ongoing projects whereas a subsidiary had 1 additional ongoing project with its contract value of Baht
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
THB 57.4mm in Q3/2019 and THB 146.9mm for the 9-month/2019, a 6% increase Q-on-Q from Q3/2018 and a 1% decrease in comparison from 9-month/2019 respectively • The majority of the changes in Q3/2019 is
results were satisfactory and confident that they could be able to help improving the Company’s business. SSG Group therefore started negotiating with 7 main trade creditors (including Cargill International
, respectively. • The decrease was mainly from the decline in operating revenue due to the temporary closure of dine-in areas from late of March to mid-May. Gross Profit and Gross Profit Margin • The Company’s
outside amounting to Baht 47.8 million. On the other hands, sales of Natural Gas Power Plants decreased by Baht 34.5 million or 6.9% because of decrease in unit rate which is adjusted in line with the
causes the company's revenue in 2022 to postpone the delivery of some projects according to the delivered equipment. The main factor for the decrease in revenue in 2022 is that the company does not have
Generating Authority of Thailand (EGAT) on 2 April 2024. Sales and service income (included revenue from finance lease under a Power Purchase Agreement) decrease 4.2% 9MYoY from Baht 4,981.3 million to Baht
the expansion of digital content via telecommunication channels service. Financial Position Unit: THB Million Financial Position As at 31 December 2020 As at 31 December 2021 Increase/ (Decrease